Skip to main content

and
  1. No Access

    Article

    Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia

    Next-generation sequencing (NGS) is an emerging technology that can comprehensively assess the diversity of the immune system. We explored the feasibility of NGS in detecting minimal residual disease (MRD) i...

    Huirong Mai, Qin Li, Guobing Wang, Ying Wang in Journal of Cancer Research and Clinical On… (2023)